|
2026 Journal Article Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statementSalani, Ritu, Atallah, David, Fader, Amanda N., Frimer, Marina, Obermair, Andreas, Pareja, Rene and Huang, Marilyn (2026). Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement. Gynecologic Oncology, 204, 109-117. doi: 10.1016/j.ygyno.2025.11.014 |
|
2025 Journal Article Extracellular vesicles as biomarkers for endometrial cancer – a systematic reviewBaxter, Eva, Nair, Soumyalekshmi, West, Zoe, Salomon, Carlos and Obermair, Andreas (2025). Extracellular vesicles as biomarkers for endometrial cancer – a systematic review. Translational Oncology, 62 102543, 1-10. doi: 10.1016/j.tranon.2025.102543 |
|
2025 Journal Article Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trialBaxter, Eva, Robledo, Kristy P., Cummings, Margaret, Alizart, Michelle, Smith, Deborah and Obermair, Andreas (2025). Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial. American Journal of Surgical Pathology. doi: 10.1097/pas.0000000000002492 |
|
2025 Journal Article LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIALBaxter, Eva, Robledo, Kristy, Gebski, Val, Chen, Chen, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James, Chetty, Naven, Janda, Monika and Obermair, Andreas (2025). LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL. International Journal of Gynecological Cancer, 35 (11) 102239, 102239. doi: 10.1016/j.ijgc.2025.102239 |
|
2025 Journal Article Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trialAl Ramadhani, Ruqaiya, Janda, Monika, Playdon, Mary and Obermair, Andreas (2025). Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trial. Current Developments in Nutrition, 9 (12) 107572, 107572. doi: 10.1016/j.cdnut.2025.107572 |
|
2025 Journal Article CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancerCohen, P.A., Obermair, A., Gebski, V., King, M.T., Butow, P., Campbell, R., Bilic, S., Brand, A., Codde, J., Goh, J.C.H., Ives, A., Kiberu, A.D., Lawson, W., Mellon, A., McNally, O., Meniawy, T., Mileshkin, L., Morton, R., Webb, P. and Friedlander, M.L. (2025). CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer. Annals of Oncology, 36, S1650. doi: 10.1016/j.annonc.2025.08.1166 |
|
2025 Journal Article Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer ConsortiumNasioudis, Dimitrios, Wohlmuth, Christoph, Albright, Benjamin, McDonald, Megan, Wallace, Sumer, Glickman, Ariel, Do, Anthony, Mantia-Smaldone, Gina, Grassi, Tommaso, Fleming, Elaine, Tsibulak, Irina, Reis, Ricardo Dos, Cucinella, Giuseppe, Heredia, Fernando, Pereira, Augusto, Bogani, Giorgio, Buckingham, Lindsey, Baiocchi, Glauco, Mills, Kathryn, AlHilli, Mariam, Obermair, Andreas, Covens, Allan, Mariani, Andrea, Plante, Marie and Giuntoli, Robert (2025). Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium. Gynecologic Oncology, 200, 18-19. doi: 10.1016/j.ygyno.2025.03.075 |
|
2025 Journal Article Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgeryWest, Simon, Jayasinghe, Dilki, Davie, Stacey and Obermair, Andreas (2025). Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery. International Journal of Gynecological Cancer, 35 (8) 101993, 101993. doi: 10.1016/j.ijgc.2025.101993 |
|
2025 Journal Article Patterns of Care for Vulval Cancer Treatment: The Queensland ExperienceDavie, S., Obermair, A. and West, Ze (2025). Patterns of Care for Vulval Cancer Treatment: The Queensland Experience. International Journal of Gynecological Cancer, 35 (7) 101956, 101956-7. doi: 10.1016/j.ijgc.2025.101956 |
|
2025 Journal Article Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancersTuesley, Karen M., Spilsbury, Katrina, Pearson, Sallie-Anne, Donovan, Peter, Obermair, Andreas, Coory, Michael D., Ali, Sitwat, Pandeya, Nirmala, Stewart, Louise, Jordan, Susan J. and Webb, Penelope M. (2025). Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers. JNCI: Journal of the National Cancer Institute, 117 (5) djae282, 1046-1055. doi: 10.1093/jnci/djae282 |
|
2025 Journal Article A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinomaObermair, A., Gebski, V., Goh, J., Kuchel, A., Brand, A., Mak, B., McNally, O., Baxter, E., Jobling, T. and Mileshkin, L. (2025). A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer, 35 (4) 101644, 1-9. doi: 10.1016/j.ijgc.2025.101644 |
|
2025 Journal Article Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancerGersekowski, Kate, DeFazio, Anna, Friedlander, Michael, Obermair, Andreas and Webb, Penelope M. (2025). Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer. Journal of Epidemiology and Community Health, 79 (9), 684-690. doi: 10.1136/jech-2024-222687 |
|
2025 Journal Article What is the true prognosis of T1a cervical cancer?Ng, Zheng Yuan, Manchanda, Ranjit, Lopez, Aldo, Obermair, Andreas, Dostalek, Lukas, Pareja, Rene, Van Lonkhuijzen, Luc R.c.w., Falconer, Henrik, Ortiz, David Isla, Fagotti, Anna, Ramirez, Pedro T., Landoni, Fabio, Weinberger, Vít, Laky, Rene, Kim, Sarah K., Klát, Jaroslav, Kocián, Roman, Nemejcova, Kristyna and Cibula, David (2025). What is the true prognosis of T1a cervical cancer?. International Journal of Gynecological Cancer, 35 (2 s1) 100442, 100442. doi: 10.1016/j.ijgc.2024.100442 |
|
2025 Journal Article Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in AustraliaNa, Renhua, Jordan, Susan J., DeFazio, Anna, Williams, Merran, Livingstone, Karen, Obermair, Andreas, Friedlander, Michael, Grant, Peter, Webb, Penelope M. and for the OPAL Study Group (2025). Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia. International Journal of Cancer, 156 (2), 280-292. doi: 10.1002/ijc.35154 |
|
2025 Journal Article Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644))Obermair, Andreas, Gebski, Val, Goh, Jeffrey, Kuchel, Anna, Brand, Alison, Mak, Blossom, McNally, Orla, Baxter, Eva, Jobling, Thomas and Mileshkin, Linda (2025). Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644)). International Journal of Gynecological Cancer, 35 (9) 101961, 101961. doi: 10.1016/j.ijgc.2025.101961 |
|
2025 Journal Article The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victimsCollings, Rachel, Potter, Christian, Gebski, Val, Janda, Monika and Obermair, Andreas (2025). The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims. American Journal of Obstetrics and Gynecology, 232 (1), 104.e1-104.e12. doi: 10.1016/j.ajog.2024.07.043 |
|
2024 Journal Article Mild symptoms matter: results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancerPlinsinga, Melanie L., Rye, Sheree, Jones, Tamara, Vagenas, Dimitrios, Ward, Leigh, Janda, Monika, Obermair, Andreas and Hayes, Sandra C. (2024). Mild symptoms matter: results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer. Gynecologic Oncology, 191, 158-164. doi: 10.1016/j.ygyno.2024.10.011 |
|
2024 Journal Article The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN studyNg, Zheng Yuan, Manchanda, Ranjit, Lopez, Aldo, Obermair, Andreas, Dostalek, Lukas, Pareja, Rene, van Lonkhuijzen, Luc R.C.W., Falconer, Henrik, Ortiz, David Isla, Fagotti, Anna, Ramirez, Pedro T., Landoni, Fabio, Weinberger, Vit, Laky, Rene, Kim, Sarah H., Klat, Jaroslav, Kocian, Roman, Pari, Darwin, Borcinova, Martina, Nemejcova, Kristyna and Cibula, David (2024). The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study. Gynecologic Oncology, 191, 95-99. doi: 10.1016/j.ygyno.2024.09.022 |
|
2024 Journal Article Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trialVirili, Florencia, Obermair, Andreas, Sanjida, Saira, Nicklin, James L., Garrett, Andrea, Land, Russell, Tang, Amy, Campbell, Louise, Gebski, Val and Thomas, Paul (2024). Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial. International Journal of Gynecologic Cancer 101854, 101854. doi: 10.1136/ijgc-2024-005633 |
|
2024 Journal Article LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer Ramirez, Pedro T., Robledo, Kristy P., Frumovitz, Michael, Pareja, Rene, Ribeiro, Reitan, Lopez, Aldo, Yan, Xiaojian, Isla, David, Moretti, Renato, Bernardini, Marcus Q., Gebski, Val, Asher, Rebecca, Behan, Vanessa, Coleman, Robert L. and Obermair, Andreas (2024). LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer . Journal of Clinical Oncology, 42 (23), 2741-2746. doi: 10.1200/jco.23.02335 |
